IndraLab

Statements


EGFR bound to IGF1R activates AKT. 1 / 1
| 1

reach
"A number of clinical studies have shown that treatment of NSCLC cells with EGFR TKIs can induce increased EGFR and IGF-1R heterodimerization and IGF-1R activation [XREF_BIBR, XREF_BIBR], enhancing the downstream PI3K and Akt and Mek and Erk pathways [XREF_BIBR]."